CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Shareholder vote results · Other events
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
Page 2 of 26 · 517 filings